Literature DB >> 20512045

Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy.

Alireza Ghotb1, Susan M Noworolski, Erin Madden, Rebecca Scherzer, Aliya Qayyum, Jane Pannell, Linda Ferrell, Marion Peters, Phyllis C Tien.   

Abstract

BACKGROUND: Hepatic steatosis is common in persons with HIV and hepatitis C virus (HCV); yet biopsy measurement of steatosis is prone to sampling error. We compared magnetic resonance spectroscopy (MRS) measurement of steatosis to histology in HIV/HCV-coinfected patients and explored the associated adipose tissue and metabolic factors.
METHODS: Cross-sectional analysis of 42 HIV/HCV-coinfected men and women. Logistic regression analysis identified factors (MRI-measured visceral adipose tissue and abdominal subcutaneous adipose tissue and Homeostasis Model Assessment-estimated insulin resistance) associated with histologic steatosis (≥ 5% of hepatocytes with fat) and MRS steatosis (≥ 5% of hepatic fat).
RESULTS: MRS steatosis was strongly associated with histologic steatosis, when measured continuously (odds ratio: 10.2 per doubling of MRS-measured hepatic fat; 95% confidence interval: 2.9 to 69.3) and dichotomously (Kappa coefficient = 0.52; P = 0.0007). Four of the 10 with MRS-measured steatosis did not have histologic steatosis; 3 of 9 with histologic steatosis did not have MRS-measured steatosis (67% sensitivity; 88% specificity). Associations of visceral adipose tissue and abdominal subcutaneous adipose tissue were associated with both histologic and MRS-measured steatosis. Insulin resistance was also associated with both.
CONCLUSIONS: When compared with histology, MRS was similarly associated with adipose tissue and metabolic factors. MRS is a useful noninvasive alternative to biopsy in HIV/HCV coinfection.

Entities:  

Mesh:

Year:  2010        PMID: 20512045      PMCID: PMC2943991          DOI: 10.1097/QAI.0b013e3181e1d963

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  15 in total

1.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population.

Authors:  Lidia S Szczepaniak; Pamela Nurenberg; David Leonard; Jeffrey D Browning; Jason S Reingold; Scott Grundy; Helen H Hobbs; Robert L Dobbins
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-08-31       Impact factor: 4.310

2.  Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.

Authors:  Maud Lemoine; Véronique Barbu; Pierre Marie Girard; Minji Kim; Jean-Philippe Bastard; Dominique Wendum; François Paye; Chantal Housset; Jacqueline Capeau; Lawrence Serfaty
Journal:  AIDS       Date:  2006-02-14       Impact factor: 4.177

3.  Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.

Authors:  Jussi Sutinen; Anna-Maija Häkkinen; Jukka Westerbacka; Anneli Seppälä-Lindroos; Satu Vehkavaara; Juha Halavaara; Asko Järvinen; Matti Ristola; Hannele Yki-Järvinen
Journal:  AIDS       Date:  2002-11-08       Impact factor: 4.177

4.  Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.

Authors:  Mark S Sulkowski; Shruti H Mehta; Michael Torbenson; Nezam H Afdhal; Lisa Mirel; Richard D Moore; David L Thomas
Journal:  AIDS       Date:  2005-03-24       Impact factor: 4.177

Review 5.  Lipodystrophies.

Authors:  A Garg
Journal:  Am J Med       Date:  2000-02       Impact factor: 4.965

6.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

7.  Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection.

Authors:  Irphan Gaslightwala; Edmund J Bini
Journal:  J Hepatol       Date:  2006-03-13       Impact factor: 25.083

8.  Respiratory motion-corrected proton magnetic resonance spectroscopy of the liver.

Authors:  Susan M Noworolski; Phyllis C Tien; Raphael Merriman; Daniel B Vigneron; Aliya Qayyum
Journal:  Magn Reson Imaging       Date:  2008-11-06       Impact factor: 2.546

9.  Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections.

Authors:  C Hézode; F Roudot-Thoraval; E-S Zafrani; D Dhumeaux; J-M Pawlotsky
Journal:  J Viral Hepat       Date:  2004-09       Impact factor: 3.728

10.  Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.

Authors:  Johan Westin; Hans Nordlinder; Martin Lagging; Gunnar Norkrans; Rune Wejstål
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

View more
  7 in total

Review 1.  Novel Approaches to Targeting Visceral and Hepatic Adiposities in HIV-Associated Lipodystrophy.

Authors:  Phyllis C Tien
Journal:  Curr Atheroscler Rep       Date:  2015-12       Impact factor: 5.113

Review 2.  Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update.

Authors:  Todd Hulgan
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

3.  Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis.

Authors:  Patrick Georgoff; David Thomasson; Adeline Louie; Estee Fleischman; Lauren Dutcher; Haresh Mani; Shyamasundaran Kottilil; Caryn Morse; Lori Dodd; David Kleiner; Colleen Hadigan
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

4.  Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.

Authors:  Jennifer C Price; Yifei Ma; Rebecca Scherzer; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan M Noworolski; Phyllis C Tien
Journal:  Hepatology       Date:  2017-02-03       Impact factor: 17.425

5.  Sex differences in the association of HIV infection with hepatic steatosis.

Authors:  Ani Kardashian; Yifei Ma; Rebecca Scherzer; Jennifer C Price; Monika Sarkar; Natalie Korn; Kyle Tillinghast; Marion G Peters; Susan M Noworolski; Phyllis C Tien
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

6.  Magnetic resonance spectroscopy to assess hepatic steatosis in patients with lipodystrophy.

Authors:  Canan Altay; Mustafa Seçil; Süleyman Cem Adıyaman; Başak Özgen Saydam; Tevfik Demir; Gülçin Akıncı; Ilgın Yıldırım Simsir; Erdal Eren; Ela Temeloğlu Keskin; Leyla Demir; Hüseyin Onay; Haluk Topaloğlu; Banu Sarer Yürekli; Nilüfer Özdemir Kutbay; Ramazan Gen; Barış Akıncı
Journal:  Turk J Gastroenterol       Date:  2020-08       Impact factor: 1.852

7.  Diagnostic value of MRI proton density fat fraction for assessing liver steatosis in chronic viral C hepatitis.

Authors:  Francesco Paparo; Giovanni Cenderello; Matteo Revelli; Lorenzo Bacigalupo; Mariangela Rutigliani; Daniele Zefiro; Luca Cevasco; Maria Amico; Roberto Bandelloni; Giovanni Cassola; Gian Luca Forni; Gian Andrea Rollandi
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.